SCHEMBL1720491

SCHEMBL1720491

COc1ccc2[nH]c(C)c(-c3nc(OC)cc(OC)n3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
GFER P55789 2/20 0.57
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
MAPT P10636 3/20 0.51
HSD17B10 Q99714 3/20 0.51
TSHR P16473 1/20 0.51
HTR6 P50406 3/20 0.51
HTR7 P34969 2/20 0.51
EIF2AK2 P19525 3/20 0.51
HTR1D P28221 2/20 0.48
MCL1 Q07820 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719927 0.84 MAP3K14 (0.51) MEN1KMT2AGFERMAPTHTR6
SCHEMBL1720216 0.82 CYP1A2 (0.55) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18019742 0.75 ALDH1A1 (0.57) MEN1KMT2AGFERALDH1A1KDM4E
SCHEMBL27495237 0.73 IDO1 (0.55) MEN1KMT2AGFERMAPTHTR6
SCHEMBL27145307 0.73 MEN1 (1.00) MEN1KMT2AGFERALDH1A1KDM4E
SCHEMBL30693718 0.73 MEN1 (1.00) MEN1KMT2AGFERALDH1A1KDM4E
SCHEMBL4374342 0.73 ALDH1A1 (0.68) MEN1KMT2AGFERALDH1A1KDM4E
SCHEMBL31105763 0.72 EIF2AK2 (0.68) MEN1KMT2AGFERALDH1A1KDM4E
SCHEMBL1719473 0.71 AHR (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL1758342 0.71 LMNA (0.63) MEN1KMT2AGFERALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334968-B1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND IHARA CHEMICAL IND CO (JP) 2012-01-11 EP disclosed
US-7820861-B2 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2010-10-26 US disclosed
EP-2025665-B1 Process for producing substituted aniline compound IHARA CHEMICAL IND CO (JP) 2010-09-15 EP disclosed
US-7531654-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-05-12 US disclosed
US-7521555-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-04-21 US disclosed
US-7504503-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-03-17 US disclosed
EP-2025665-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2009-02-18 EP disclosed
US-7271263-B2 Process for production of substituted aniline compound IHARA CHEMICAL INDUSTRY, CO., LTD. (JP) 2007-09-18 US disclosed
US-20070213561-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213532-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213533-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20060281765-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-12-14 US disclosed
US-20040034251-A1 Process for production of substituted aniline compound 1HARA CHEMICAL INDUSTRY CO., LT.D. (JP) 2004-02-19 US disclosed
EP-1334968-A1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND Ihara Chemical Industry Co., Ltd. (JP) 2003-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034251-A1 Process for production of substituted aniline compound NAT1, CBR3, AADAC MEN1 4483/4885KMT2A 824/4885GFER 179/4885
US-20070213561-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MEN1 4270/4885KMT2A 837/4885GFER 126/4885
US-20060281765-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MEN1 4270/4885KMT2A 837/4885GFER 126/4885
US-20070213532-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MEN1 4270/4885KMT2A 837/4885GFER 126/4885
US-20070213533-A1 Process for producing substituted aniline compound AADAC, NAT1, CBR3 MEN1 4390/4885KMT2A 652/4885GFER 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.